This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: F. Hoffmann-La Roche Ag, Prothena Biosciences Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 181 
1 out of 64 
Years Active: 2026
Title: Valérie Cosson: Innovator in Synucleinopathies Treatment
Introduction
Valérie Cosson is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of medical research, particularly in the treatment of synucleinopathies. Her innovative work has led to the development of a patent that addresses critical aspects of this complex condition.
Latest Patents
Valérie Cosson holds a patent titled "Dosing Regimes for Treatment of Synucleinopathies." This patent represents her commitment to advancing therapeutic strategies for diseases associated with abnormal protein aggregation, which are crucial for improving patient outcomes.
Career Highlights
Throughout her career, Valérie has worked with notable companies, including F. Hoffmann-La Roche AG and Prothena Biosciences Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Valérie has collaborated with talented individuals such as Jay Soto and Daniel Keith Ness. These partnerships have enriched her work and fostered an environment of innovation and discovery.
Conclusion
Valérie Cosson's contributions to the treatment of synucleinopathies through her patent and collaborations highlight her role as a key innovator in the medical field. Her work continues to inspire advancements in therapeutic approaches for complex neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile